168 related articles for article (PubMed ID: 18637237)
1. Quantification of enhancement in contrast ultrasound: a tool for monitoring of therapies in liver metastases.
Krix M
Eur Radiol; 2005 Dec; 15 Suppl 5():E104-8. PubMed ID: 18637237
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterisation of liver metastases.
Albrecht T; Hohmann J; Oldenburg A; Skrok J; Wolf KJ
Eur Radiol; 2004 Oct; 14 Suppl 8():P25-33. PubMed ID: 15700330
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results.
Krix M; Plathow C; Essig M; Herfarth K; Debus J; Kauczor HU; Delorme S
Eur Radiol; 2005 Apr; 15(4):677-84. PubMed ID: 15729565
[TBL] [Abstract][Full Text] [Related]
4. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
5. Unenhanced and contrast-enhanced ultrasonography during hepatic transarterial embolization and chemoembolization with drug-eluting beads.
Moschouris H; Malagari K; Kornezos I; Papadaki MG; Gkoutzios P; Matsaidonis D
Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1215-22. PubMed ID: 20556386
[TBL] [Abstract][Full Text] [Related]
6. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
8. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound.
Solbiati L; Ierace T; Tonolini M; Cova L
Eur J Radiol; 2004 Jun; 51 Suppl():S19-23. PubMed ID: 15311434
[TBL] [Abstract][Full Text] [Related]
9. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasonography with intraarterial administration of SonoVue for guidance of transarterial chemoembolization: an initial experience.
Moschouris H; Malagari K; Kalokairinou M; Stamatiou K; Marinis A; Papadaki MG
Med Ultrason; 2011 Dec; 13(4):296-301. PubMed ID: 22132402
[TBL] [Abstract][Full Text] [Related]
12. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
Seitz K; Strobel D
Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
14. Doppler perfusion index and contrast-enhanced ultrasound in patients with colorectal cancer liver metastases.
Ruan L; Wang S; Zhang J; Ai H; Zhao Q; Yang J; Wei W
Hepatogastroenterology; 2014; 61(129):37-41. PubMed ID: 24895790
[TBL] [Abstract][Full Text] [Related]
15. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue.
Oldenburg A; Hohmann J; Foert E; Skrok J; Hoffmann CW; Frericks B; Wolf KJ; Albrecht T
Ultraschall Med; 2005 Aug; 26(4):277-84. PubMed ID: 16123921
[TBL] [Abstract][Full Text] [Related]
16. Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography.
Krix M; Kiessling F; Essig M; Herth F; Karcher A; Le-Huu M; Kauczor HU; Delorme S
Invest Radiol; 2004 Apr; 39(4):216-22. PubMed ID: 15021325
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound features of hepatocellular adenoma and the additional value of contrast-enhanced ultrasound.
Dong Y; Zhu Z; Wang WP; Mao F; Ji ZB
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):48-54. PubMed ID: 26818543
[TBL] [Abstract][Full Text] [Related]
18. Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents.
Krix M; Plathow C; Kiessling F; Herth F; Karcher A; Essig M; Schmitteckert H; Kauczor HU; Delorme S
Ultrasound Med Biol; 2004 Oct; 30(10):1355-63. PubMed ID: 15582235
[TBL] [Abstract][Full Text] [Related]
19. Effect of observer experience in the differentiation between benign and malignant liver tumors after ultrasound contrast agent injection.
Quaia E; Alaimo V; Baratella E; Pizzolato R; Cester G; Medeot A; Cova MA
J Ultrasound Med; 2010 Jan; 29(1):25-36. PubMed ID: 20040772
[TBL] [Abstract][Full Text] [Related]
20. Intracavitary applications of ultrasound contrast agents in hepatogastroenterology.
Sparchez Z; Radu P; Sparchez M; Vasile T; Anton O; Tantau M
J Gastrointestin Liver Dis; 2013 Sep; 22(3):349-53. PubMed ID: 24078996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
